The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
Cisplatin based hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to prolong recurrence free and overall survival of women with ovarian cancer who have responded to neoadjuvant chemotherapy. The aim of this study was to assess the impact of cytoreductive surgery with or without the ad...
Main Authors: | Kate Glennon, Karen Mulligan, Kirsten Carpenter, Ruth Mooney, Jurgen Mulsow, Orla McCormack, William Boyd, Tom Walsh, Ruaidhri McVey, Claire Thompson, Brid Ryan, Katie Padfield, Patrick Murray, Donal J Brennan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578921001004 |
Similar Items
-
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01) -
Hyperthermic Intraperitoneal Chemotherapy: A Critical Review
by: Wim Ceelen, et al.
Published: (2021-06-01) -
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: Olivia G. Huffman, et al.
Published: (2023-02-01) -
Laparoscopy for risk-reducing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (case series and review of literature)
by: Vedrana Biošić, et al.
Published: (2023-01-01) -
The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
by: Beatrice J. Sun, et al.
Published: (2023-10-01)